Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Trials
|
January 31, 2014
A rehabilitation intervention to promote physical recovery following intensive care: a detailed description of construct development, rationale and content together with proposed taxonomy to capture processes in a randomised controlled trial
Pam Ramsay, Lisa G Salisbury, Judith L Merriweather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2006
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII
Jürg Bernhard, David Zahrieh, Monica Castiglione-Gertsch, et al.
Trials
|
October 8, 2011
Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians)
Anne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Lancet (London, England)
|
December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
John F Forbes, Ivana Sestak, Anthony Howell, et al.
Stroke
|
April 18, 2020
Association Between Walking Pace and Stroke Incidence: Findings From the UK Biobank Prospective Cohort Study
Sara Hayes, John F Forbes, Carlos Celis-Morales, et al.
The Lancet. Oncology
|
June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types
Sherene Loi, W Fraser Symmans, John M S Bartlett, et al.
The New England Journal of Medicine
|
December 31, 2005
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
, Beat Thürlimann, Aparna Keshaviah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
, Carl-Magnus Rudenstam, David Zahrieh, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Trials
|
January 31, 2014
A rehabilitation intervention to promote physical recovery following intensive care: a detailed description of construct development, rationale and content together with proposed taxonomy to capture processes in a randomised controlled trial
Pam Ramsay, Lisa G Salisbury, Judith L Merriweather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2006
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII
Jürg Bernhard, David Zahrieh, Monica Castiglione-Gertsch, et al.
Trials
|
October 8, 2011
Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians)
Anne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Lancet (London, England)
|
December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
John F Forbes, Ivana Sestak, Anthony Howell, et al.
Stroke
|
April 18, 2020
Association Between Walking Pace and Stroke Incidence: Findings From the UK Biobank Prospective Cohort Study
Sara Hayes, John F Forbes, Carlos Celis-Morales, et al.
The Lancet. Oncology
|
June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types
Sherene Loi, W Fraser Symmans, John M S Bartlett, et al.
The New England Journal of Medicine
|
December 31, 2005
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
, Beat Thürlimann, Aparna Keshaviah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
, Carl-Magnus Rudenstam, David Zahrieh, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Page
of 9